|
Volumn 330, Issue 7484, 2005, Pages 156-157
|
Opioids for persistent non-cancer pain
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE;
ANALGESIA;
BEHAVIOR THERAPY;
CANCER PAIN;
CHRONIC PAIN;
CLINICAL TRIAL;
COGNITIVE THERAPY;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
DIABETIC NEPHROPATHY;
DIZZINESS;
DROWSINESS;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MONITORING;
DRUG SAFETY;
EDITORIAL;
EXERCISE;
HEADACHE;
HUMAN;
META ANALYSIS;
MYALGIA;
NAUSEA;
NEUROPATHIC PAIN;
PAIN;
PAIN CLINIC;
PATIENT MONITORING;
POSTHERPETIC NEURALGIA;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PRURITUS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
SEDATION;
SOMNOLENCE;
SYSTEMATIC REVIEW;
TRANSCUTANEOUS NERVE STIMULATION;
VOMITING;
XEROSTOMIA;
|
EID: 12444275556
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.330.7484.156 Document Type: Editorial |
Times cited : (15)
|
References (6)
|